Predictors of response to opicinumab in acute optic neuritis

about

Predictors of response to opicinumab in acute optic neuritis

Item

http://www.wikidata.org/entity/Q57823883

description

article

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в жовтні 2018

@uk

name

Predictors of response to opicinumab in acute optic neuritis

@en

Predictors of response to opicinumab in acute optic neuritis

@nl

type

Item

label

Predictors of response to opicinumab in acute optic neuritis

@en

Predictors of response to opicinumab in acute optic neuritis

@nl

prefLabel

Predictors of response to opicinumab in acute optic neuritis

@en

Predictors of response to opicinumab in acute optic neuritis

@nl

P1476

Predictors of response to opicinumab in acute optic neuritis

@en

P2093

Diego Cadavid

http://www.w3.org/2001/XMLSchema#string

Focke Ziemssen

http://www.w3.org/2001/XMLSchema#string

Gordon T Plant

http://www.w3.org/2001/XMLSchema#string

Jana Lizrova Preiningerova

http://www.w3.org/2001/XMLSchema#string

Lei Xu

http://www.w3.org/2001/XMLSchema#string

Letizia Leocani

http://www.w3.org/2001/XMLSchema#string

Luca Massacesi

http://www.w3.org/2001/XMLSchema#string

Ludo J Vanopdenbosch

http://www.w3.org/2001/XMLSchema#string

Mark S Freedman

http://www.w3.org/2001/XMLSchema#string

Orhan Aktas

http://www.w3.org/2001/XMLSchema#string

P2860

Acute optic neuritis: Unmet clinical needs and model for new therapies

Age-dependent epigenetic control of differentiation inhibitors is critical for remyelination efficiency

Multiple sclerosis: current and emerging disease-modifying therapies and treatment strategies.

Recovery after optic neuritis in childhood.

Blocking LINGO-1 as a therapy to promote CNS repair: from concept to the clinic.

Randomized phase I trials of the safety/tolerability of anti-LINGO-1 monoclonal antibody BIIB033

Fully automatic software for retinal thickness in eyes with diabetic macular edema from images acquired by cirrus and spectralis systems

Glia Disease and Repair-Remyelination

Rejuvenation of regeneration in the aging central nervous system.

Safety and efficacy of opicinumab in acute optic neuritis (RENEW): a randomised, placebo-controlled, phase 2 trial.

P304

1154-1162

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ACN3.620

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Tjalf Ziemssen

Steven Galetta

Laura J Balcer

P577

2018-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30349850

http://www.w3.org/2001/XMLSchema#string

P932

6186935

http://www.w3.org/2001/XMLSchema#string